Updated: January 9, 2026
Rinvoq XR Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Rinvoq XR has a Boxed Warning and a range of side effects. Here's what patients actually experience, what's manageable, and what requires an urgent call to your doctor.
Before starting any medication, it's important to understand the full picture of what you might experience. Rinvoq XR (upadacitinib) is an effective JAK inhibitor, but it carries real risks — including an FDA Boxed Warning, the agency's most serious level of caution. Here's a clear breakdown of what to expect, what's manageable at home, and what requires an urgent call to your doctor.
The FDA Boxed Warning: What It Means for You
Rinvoq XR carries a Boxed Warning — the FDA's strongest safety signal — covering five serious risks. This doesn't mean you'll definitely experience these, but they're serious enough that your doctor needs to evaluate your individual risk before prescribing:
Serious infections: Rinvoq XR lowers your immune defenses. Serious infections — including tuberculosis (TB), bacterial infections, and fungal infections — have occurred. Some have been fatal. You'll be tested for TB before starting.
Increased mortality: Patients 50 years and older with at least one cardiovascular risk factor have shown increased risk of death in studies of similar drugs. Your doctor will evaluate whether the benefit outweighs this risk for you.
Malignancies: Including lymphoma and other cancers. Risk is higher in current or past smokers and in patients over 50 with cardiovascular risk factors.
Major adverse cardiovascular events (MACE): Heart attack, stroke, and cardiovascular death. Risk is elevated in patients with existing heart disease risk factors.
Thrombosis: Deep vein thrombosis (DVT), pulmonary embolism (PE), and arterial clots. Stop taking Rinvoq XR and call your doctor immediately if you develop sudden shortness of breath, chest pain, leg swelling, or leg pain.
Common Side Effects (Reported in ≥1% of Patients)
These are the side effects most frequently reported across clinical trials. Most are manageable and often improve over time:
Upper respiratory infections (most common) — colds, sinus infections, sore throat. These are usually mild and self-resolving.
Herpes zoster (shingles) — more common than in the general population. Getting vaccinated against shingles before starting Rinvoq XR is strongly recommended.
Acne — a common and typically mild side effect, especially in the first few months. Your dermatologist can help manage this if it's bothersome.
Nausea — often mild and improves over time. Taking the medication with food may help.
Cough — commonly reported but typically mild.
Headache — particularly in atopic dermatitis patients.
Elevated CPK (creatine phosphokinase) — detected on blood tests; usually not clinically significant.
Elevated liver enzymes — monitored with periodic blood tests; your doctor will watch for this.
Neutropenia — low white blood cell count detected on labs; may require dose adjustment or temporary stopping.
Lab Abnormalities to Monitor
Your doctor will order regular blood tests while you're on Rinvoq XR. Key things they're monitoring include:
CBC with differential — monitoring for neutropenia, lymphopenia, or anemia
Liver function tests (LFTs) — monitoring for elevated liver enzymes
Lipid panel — JAK inhibitors can increase LDL and total cholesterol
CPK — monitoring for muscle enzyme elevation
When to Call Your Doctor Immediately
Stop taking Rinvoq XR and call your doctor or go to the ER immediately if you experience:
Sudden shortness of breath or chest pain (possible PE or heart attack)
Leg swelling, pain, or warmth (possible DVT)
High fever, chills, or feeling very sick (possible serious infection)
Severe or worsening abdominal pain (possible GI perforation)
Signs of a stroke: sudden facial drooping, arm weakness, or speech difficulty
Severe skin reaction or anaphylaxis: hives, swelling of face/throat, difficulty breathing
Painful, blistering rash — possible shingles (herpes zoster)
Medication Residue in Stool
Some patients — particularly those with faster GI transit times, ostomies, or inflammatory bowel disease — may notice the tablet shell in their stool. This does NOT mean the medication hasn't worked. The active drug is absorbed before the shell passes through. However, if you have shortened GI transit times and your condition isn't improving, inform your doctor so they can evaluate whether absorption is adequate.
Also read: Rinvoq XR Drug Interactions: What to Avoid and What to Tell Your Doctor
Frequently Asked Questions
The most common side effects of Rinvoq XR (upadacitinib) include upper respiratory tract infections (colds, sinus infections), herpes zoster (shingles), acne, nausea, cough, headache, elevated CPK, elevated liver enzymes, and neutropenia. Most are mild to moderate and often improve over time.
Yes, acne is a commonly reported side effect of Rinvoq XR, especially in the first few months of treatment. It appears to be a class effect of JAK inhibitors. For most patients, it is mild and manageable. Talk to your dermatologist if it is bothersome — topical treatments can help without affecting Rinvoq XR's efficacy.
Live vaccines (such as the live shingles vaccine Zostavax) are contraindicated while taking Rinvoq XR. Non-live vaccines are generally acceptable and recommended. Ideally, you should update all recommended vaccines — especially the recombinant shingles vaccine (Shingrix) — before starting Rinvoq XR. Discuss your vaccine history with your doctor.
Seek emergency care immediately if you experience sudden chest pain, shortness of breath, or signs of a stroke or blood clot while on Rinvoq XR. Also seek urgent care for high fever with chills, severe abdominal pain, or a painful blistering rash (shingles). These can be signs of serious complications including thrombosis, infection, or GI perforation.
Yes. Rinvoq XR carries a Boxed Warning for thrombosis, including deep vein thrombosis (DVT) and pulmonary embolism (PE). The risk appears higher in patients with existing cardiovascular risk factors. Avoid Rinvoq XR if you have a history of blood clots unless your doctor has carefully evaluated the benefits vs. risks for your situation.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Rinvoq XR also looked for:
More about Rinvoq XR
29,430 have already found their meds with Medfinder.
Start your search today.





